← Back to Clinical Trials
Recruiting NCT06219200

NCT06219200 Automatic Voice Analysis for Dysphagia Screening in Neurological Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06219200
Status Recruiting
Phase
Sponsor Istituti Clinici Scientifici Maugeri SpA
Condition Deglutition Disorders
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2023-10-11
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2023-10-11 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The proposed study suggests using automatic voice analysis and machine learning algorithms to develop a dysphagia screening tool for neurological patients. The research involves patients with Parkinson's disease, stroke, and amyotrophic lateral sclerosis, both with and without dysphagia, along with healthy individuals. Participants perform various vocal tasks during a single recording session. Voice signals are analysed and used as input for machine learning classification algorithms. The significance of this study is that oropharyngeal dysphagia, a condition involving swallowing difficulties in the transit of food or liquids from the mouth to the esophagus, generates malnutrition, dehydration, and pneumonia, significantly contributing to management costs and hospitalization durations. Currently, there is a lack of rapid and effective dysphagia screening methods for healthcare personnel, with only expensive invasive tests and clinical scales in use.

Eligibility Criteria

Inclusion Criteria: * Patients with a diagnosis of stroke, Parkinson's disease, or amyotrophic lateral sclerosis, or healthy individuals. * Age higher than 18 years old. Exclusion Criteria: * Cognitive impairment that do not allow participants to understand the requested vocal tasks. * Ear, nose,throat diseases and other disorders able to affect voice quality.

Contact & Investigator

Central Contact

Beatrice De Maria, PhD

✉ beatrice.demaria@icsmaugeri.it

📞 0250725

Frequently Asked Questions

Who can join the NCT06219200 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Deglutition Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06219200 currently recruiting?

Yes, NCT06219200 is actively recruiting participants. Contact the research team at beatrice.demaria@icsmaugeri.it for enrollment information.

Where is the NCT06219200 trial being conducted?

This trial is being conducted at Lissone, Italy, Milan, Italy.

Who is sponsoring the NCT06219200 clinical trial?

NCT06219200 is sponsored by Istituti Clinici Scientifici Maugeri SpA. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology